Received Mar 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y015559 | — |
No symptoms reported. No additional AE details reported.; a patient who was administered improperly stored VARIVAX on 2/17/2025; This spontaneous report was received from an Other health professional and referred to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 18-Feb-2025, the patient was vaccinated with the improperly stored Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Y015559, expiration date: 16-Sep-2026) (0.5ml/dose) for prophylaxis; The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT). It was reported that the suspect vaccine was underwent temperature excursions (minus 13.9C or minus 14C up to minus 10C) for 10 Minutes on 14-Feb-2025 (product storage error). There were no previous temperature excursions. No additional adverse event (AE) was reported (no adverse event).
sterile diluent